Homepage-4

In the spirit of Yuhan’s global open innovation initiative, Yuhan USA  is searching for business development and collaboration opportunities in new drug assets that match our strategic focus areas and companies that share our drive towards excellence in medicine.

1926

Founded

No.1

Top Selling Pharma in S. Korea (1.2 B USD, 2019)

17 yrs

Voted as Most Respected Company in S. Korea

25

Total Number of R&D Programs

10.1%

R&D Investment on Net Sales (2019)

~2,000

Employees/R&D Staff

Our Partners

A strong track record of successful collaborative partnerships across the globe